PofoliaShared via Pofolia

Pain Medicine· 2013Q1

Sustained Effectiveness of 10 kHz High-Frequency Spinal Cord Stimulation for Patients with Chronic, Low Back Pain: 24-Month Results of a Prospective Multicenter Study

Adnan Al‐Kaisy, Jean‐Pierre Van Buyten, Iris Smet, Stefano Palmisani et al.

Short summary

High-frequency spinal cord stimulation (HF10 SCS) at 10 kHz provided sustained pain relief for chronic low back pain patients, with 90% of implanted patients reporting significant improvement at 24 months.

AI-generated from the title and abstract; the full text is not read.

Key points

  • 88% of patients with chronic low back pain showed significant pain improvement after a trial of HF10 SCS and proceeded to permanent implantation.
  • At 24 months, mean back pain was reduced by 5.1 points (from 8.4 to 3.3) and leg pain by 3.1 points (from 5.4 to 2.3).
  • HF10 SCS was associated with significant reductions in disability (Oswestry Disability Index), sleep disturbances, and opioid use.
  • Adverse events were comparable to traditional spinal cord stimulation systems.

AI-generated from the title and abstract; the full text is not read.

Abstract

OBJECTIVE: The aim of this study was to investigate the long-term efficacy and safety of paresthesia-free high-frequency spinal cord stimulation (HF10 SCS) for the treatment of chronic, intractable pain of the low back and legs. DESIGN: Prospective, multicenter, observational study. METHOD: Patients with significant chronic low back pain underwent implantation of a spinal cord stimulator capable of HF10 SCS. Patients' pain ratings, disability, sleep disturbances, opioid use, satisfaction, and adverse events were assessed for 24 months. RESULTS: After a trial period, 88% (72 of 82) of patients reported a significant improvement in pain scores and underwent the permanent implantation of the system. Ninety percent (65 of 72) of patients attended a 24-month follow-up visit. Mean back pain was reduced from 8.4 ± 0.1 at baseline to 3.3 ± 0.3 at 24 months (P < 0.001), and mean leg pain from 5.4 ± 0.4 to 2.3 ± 0.3 (P < 0.001). Concomitantly to the pain relief, there were significant decreases in opioid use, Oswestry Disability Index score, and sleep disturbances. Patients' satisfaction and recommendation ratings were high. Adverse Events were similar in type and frequency to those observed with traditional SCS systems. CONCLUSIONS: In patients with chronic low back pain, HF10 SCS resulted in clinically significant and sustained back and leg pain relief, functional and sleep improvements, opioid use reduction, and high patient satisfaction. These results support the long-term safety and sustained efficacy of HF10 SCS.

The authors' abstract, as published at the source. Pain Medicine, 2013 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Anesthesiology and Pain Medicine

Anesthesiology and Pain MedicineMedicine